Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Cincinnati |
---|---|
Information provided by: | University of Cincinnati |
ClinicalTrials.gov Identifier: | NCT00608296 |
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
Condition |
---|
Bipolar |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Estimated Enrollment: | 120 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | July 2013 |
Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1
Study subjects on lithium
|
2
study subjects on quetiapine
|
3
healthy control
|
Ages Eligible for Study: | 16 Years to 35 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
You are being asked to take part in this research study because you have been diagnosed with bipolar disorder and are currently experiencing a depressive episode. Bipolar disorder is an illness characterized by recurrent mood swings including mania, (periods of elation, excessive excitement, irritability, high energy, racing thoughts, poor sleep, poor judgment, reckless behavior) and clinical depression (periods of depressed mood, loss of interest in activities and disruption of sleep, appetite and energy). To participate in this study you must be at least 16 years old, and no older than 35.
Inclusion Criteria - Depressed bipolar patients (N=80; 15-20 patients/year):
Inclusion Criteria - Healthy subjects (N=40; 8-10 subjects/year):
Exclusion criteria: All subjects will be excluded from participation for the following reasons:
Contact: Jonathon Schroer, BA, BPh | 513-558-3991 | jonathon.schroer@uc.edu |
United States, Ohio | |
University of Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45267-0559 |
Principal Investigator: | Caleb M Adler, MD | University of Cincinnati |
Responsible Party: | University of Cincinnati ( Caleb M. Adler, MD ) |
Study ID Numbers: | BITREC - Project II |
Study First Received: | January 23, 2008 |
Last Updated: | July 21, 2008 |
ClinicalTrials.gov Identifier: | NCT00608296 |
Health Authority: | United States: Institutional Review Board |
Depression Depressive Disorder |